๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sodium Channel Blockers for the Treatment of Neuropathic Pain

โœ Scribed by Anindya Bhattacharya; Alan D. Wickenden; Sandra R. Chaplan


Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
599 KB
Volume
6
Category
Article
ISSN
1933-7213

No coin nor oath required. For personal study only.

โœฆ Synopsis


Drugs that block voltage-gated sodium channels are efficacious in the management of neuropathic pain. Accordingly, this class of ion channels has been a major focus of analgesic research both in academia and in the pharmaceutical/biotechnology industry. In this article, we review the history of the use of sodium channel blockers, describe the current status of sodium channel drug discovery, highlight the challenges and hurdles to attain sodium channel subtype selectivity, and review the potential usefulness of selective sodium channel blockers in neuropathic pain.


๐Ÿ“œ SIMILAR VOLUMES


Butyl 2-(4-[1.1โ€ฒ-Biphenyl]-4-yl-1H-imida
โœ Anne-Marie Liberatore; et al. et al. ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons โš– 12 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Discovery of a novel class of biphenyl p
โœ Sriram Tyagarajan; Prasun K. Chakravarty; Bishan Zhou; Brett Taylor; Ronsar Eid; ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 444 KB

A series of novel biphenyl pyrazole dicarboxamides were identified as potential sodium channel blockers for treatment of neuropathic pain. Compound 20 had outstanding efficacy in the Chung rat spinal nerve ligation (SNL) model of neuropathic pain.